RankingsPricing
  1. US-listed companies
  2. CATALYST PHARMACEUTICALS, INC.
  3. Financials
  4. Return on Assets

CATALYST PHARMACEUTICALS, INC.【CPRX】

Market cap
$2.8B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 202424.8+46.83%
Dec 31, 202316.9-37.65%
Dec 31, 202227.1+47.55%
Dec 31, 202118.4-62.69%
Dec 31, 202049.2+33.40%
Dec 31, 201936.9-179.11%
Dec 31, 2018-46.6+60.96%
Dec 31, 2017-29-18.39%
Dec 31, 2016-35.5-8.76%
Dec 31, 2015-38.9-13.09%
Dec 31, 2014-44.8-22.36%
Dec 31, 2013-57.7+62.93%
Dec 31, 2012-35.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)